Downregulation of thioredoxin-1 in the ventral tegmental area delays extinction of methamphetamine-induced conditioned place preference. 2018

Mengbing Huang, and Ming Bai, and Zhimin Zhang, and Lu Ge, and Kang Lu, and Xiang Li, and Ye Li, and Xiaoshuang Zhou, and Ningning Guo, and Lihua Yang, and Jie Bai
1 Medical Faculty, Kunming University of Science and Technology, Kunming, China.

Drug addiction is characterized by compulsive drug use and relapse. Thioredoxin-1 is emerging as an important modulator involved in the cellular protective response against a variety of toxic stressors. Previous study has reported that thioredoxin-1 overexpression prevents the acquisition of methamphetamine-conditioned place preference. Here, we aimed to investigate the effect of thioredoxin-1 on methamphetamine-conditioned place preference extinction and the possible mechanism. (a) An extinction procedure in mice was employed to investigate the effect of thioredoxin-1 on the extinction of methamphetamine-conditioned place preference. After the acquisition of methamphetamine-conditioned place preference, mice underwent the following procedures: the injection of thioredoxin-1 small interfering RNA in the ventral tegmental area followed by the post-conditioned place preference test, four days of extinction training followed by four days of recovery after surgery. (b) The levels of thioredoxin-1, dopamine D1 receptor, tyrosine hydroxylase, phosphorylated extracellular regulated kinase, and phosphorylated cyclic adenosine monophosphate response element binding protein were examined by using Western blot analysis. Thioredoxin-1 downregulation in the ventral tegmental area delayed methamphetamine-conditioned place preference extinction. The expression of thioredoxin-1 was decreased in the ventral tegmental area of mice in control and negative groups after methamphetamine-conditioned place preference extinction, but not in the thioredoxin-1 siRNA group. The levels of dopamine D1 receptor, tyrosine hydroxylase, phosphorylated extracellular regulated kinase, and phosphorylated cyclic adenosine monophosphate response element binding protein were decreased in the ventral tegmental area, nucleus accumbens, and prefrontal cortex of mice in the control and negative groups after methamphetamine-conditioned place preference extinction, but were inversely increased in thioredoxin-1 siRNA group. The results suggest that downregulation of thioredoxin-1 in the ventral tegmental area may delay methamphetamine-conditioned place preference extinction by regulating the mesocorticolimbic dopaminergic signaling pathway.

UI MeSH Term Description Entries
D008297 Male Males
D008694 Methamphetamine A central nervous system stimulant and sympathomimetic with actions and uses similar to DEXTROAMPHETAMINE. The smokable form is a drug of abuse and is referred to as crank, crystal, crystal meth, ice, and speed. Deoxyephedrine,Desoxyephedrine,Desoxyn,Madrine,Metamfetamine,Methamphetamine Hydrochloride,Methylamphetamine,N-Methylamphetamine,Hydrochloride, Methamphetamine,N Methylamphetamine
D008845 Microinjections The injection of very small amounts of fluid, often with the aid of a microscope and microsyringes. Microinjection
D009714 Nucleus Accumbens Collection of pleomorphic cells in the caudal part of the anterior horn of the LATERAL VENTRICLE, in the region of the OLFACTORY TUBERCLE, lying between the head of the CAUDATE NUCLEUS and the ANTERIOR PERFORATED SUBSTANCE. It is part of the so-called VENTRAL STRIATUM, a composite structure considered part of the BASAL GANGLIA. Accumbens Nucleus,Nucleus Accumbens Septi,Accumbens Septi, Nucleus,Accumbens Septus, Nucleus,Accumbens, Nucleus,Nucleus Accumbens Septus,Nucleus, Accumbens,Septi, Nucleus Accumbens,Septus, Nucleus Accumbens
D010766 Phosphorylation The introduction of a phosphoryl group into a compound through the formation of an ester bond between the compound and a phosphorus moiety. Phosphorylations
D003214 Conditioning, Classical Learning that takes place when a conditioned stimulus is paired with an unconditioned stimulus. Reflex, Conditioned,Classical Conditioning,Classical Conditionings,Conditioned Reflex,Conditionings, Classical
D005108 Extinction, Psychological The procedure of presenting the conditioned stimulus without REINFORCEMENT to an organism previously conditioned. It refers also to the diminution of a conditioned response resulting from this procedure. Psychological Extinction,Extinction (Psychology),Extinctions (Psychology),Extinctions, Psychological,Psychological Extinctions
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013879 Thioredoxins Hydrogen-donating proteins that participates in a variety of biochemical reactions including ribonucleotide reduction and reduction of PEROXIREDOXINS. Thioredoxin is oxidized from a dithiol to a disulfide when acting as a reducing cofactor. The disulfide form is then reduced by NADPH in a reaction catalyzed by THIOREDOXIN REDUCTASE. Thioredoxin,Thioredoxin 1,Thioredoxin 2,Thioredoxin-1,Thioredoxin-2
D014446 Tyrosine 3-Monooxygenase An enzyme that catalyzes the conversion of L-tyrosine, tetrahydrobiopterin, and oxygen to 3,4-dihydroxy-L-phenylalanine, dihydrobiopterin, and water. EC 1.14.16.2. Tyrosine Hydroxylase,3-Monooxygenase, Tyrosine,Hydroxylase, Tyrosine,Tyrosine 3 Monooxygenase

Related Publications

Mengbing Huang, and Ming Bai, and Zhimin Zhang, and Lu Ge, and Kang Lu, and Xiang Li, and Ye Li, and Xiaoshuang Zhou, and Ningning Guo, and Lihua Yang, and Jie Bai
September 2023, Behavioural brain research,
Mengbing Huang, and Ming Bai, and Zhimin Zhang, and Lu Ge, and Kang Lu, and Xiang Li, and Ye Li, and Xiaoshuang Zhou, and Ningning Guo, and Lihua Yang, and Jie Bai
December 2013, Journal of behavioral and brain science,
Mengbing Huang, and Ming Bai, and Zhimin Zhang, and Lu Ge, and Kang Lu, and Xiang Li, and Ye Li, and Xiaoshuang Zhou, and Ningning Guo, and Lihua Yang, and Jie Bai
February 2005, Behavioral neuroscience,
Mengbing Huang, and Ming Bai, and Zhimin Zhang, and Lu Ge, and Kang Lu, and Xiang Li, and Ye Li, and Xiaoshuang Zhou, and Ningning Guo, and Lihua Yang, and Jie Bai
December 2023, Addiction biology,
Mengbing Huang, and Ming Bai, and Zhimin Zhang, and Lu Ge, and Kang Lu, and Xiang Li, and Ye Li, and Xiaoshuang Zhou, and Ningning Guo, and Lihua Yang, and Jie Bai
April 2011, Behavioral neuroscience,
Mengbing Huang, and Ming Bai, and Zhimin Zhang, and Lu Ge, and Kang Lu, and Xiang Li, and Ye Li, and Xiaoshuang Zhou, and Ningning Guo, and Lihua Yang, and Jie Bai
February 2021, Behavioural pharmacology,
Mengbing Huang, and Ming Bai, and Zhimin Zhang, and Lu Ge, and Kang Lu, and Xiang Li, and Ye Li, and Xiaoshuang Zhou, and Ningning Guo, and Lihua Yang, and Jie Bai
October 2016, Behavioural brain research,
Mengbing Huang, and Ming Bai, and Zhimin Zhang, and Lu Ge, and Kang Lu, and Xiang Li, and Ye Li, and Xiaoshuang Zhou, and Ningning Guo, and Lihua Yang, and Jie Bai
March 2016, Psychopharmacology,
Mengbing Huang, and Ming Bai, and Zhimin Zhang, and Lu Ge, and Kang Lu, and Xiang Li, and Ye Li, and Xiaoshuang Zhou, and Ningning Guo, and Lihua Yang, and Jie Bai
May 2010, Journal of neuroscience research,
Mengbing Huang, and Ming Bai, and Zhimin Zhang, and Lu Ge, and Kang Lu, and Xiang Li, and Ye Li, and Xiaoshuang Zhou, and Ningning Guo, and Lihua Yang, and Jie Bai
May 2007, European journal of pharmacology,
Copied contents to your clipboard!